POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

Abroad (travel likely)Recruiting

Conditions

Type 2 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

GBUZ hospital, Anapa, Russia

Study leads

Marina Shestakova
Principal Investigator
Endocrinology Research Centre

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Escondido, United States

Preventing T2DM After GDM With Immediate Postpartum Screening

Gestational Diabetes · Type 2 Diabetes

Abroad (travel likely)Recruiting

Worcester, United States

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Type 2 Diabetes

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Canoga Park, United States

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Type 2 Diabetes · Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

Abroad (travel likely)RecruitingPHASE4

Nanjing, China